Natsumi Kawasaki

Publication Activity (10 Years)

Years Active: 2017-2023
Publications (10 Years): 4

Top Topics

Hodgkin Lymphoma

Combination Therapy

Endoplasmic Reticulum Stress

Top Venues

Leukemia & lymphoma

Scientific reports

British journal of haematology

Molecular cancer therapeutics

This page only lists publications with an associated author ORCID identifier.

Publications

Natsumi Kawasaki, Mayu Tomita, Yoriko Yamashita-Kashima, Yasushi Yoshimura, Shigeki Yoshiura
Efficacy of retreatment with polatuzumab vedotin in combination with rituximab in polatuzumab vedotin-resistant DLBCL models. Leukemia & lymphoma (2023)
Natsumi Kawasaki, Yukari Nishito, Yasushi Yoshimura, Shigeki Yoshiura
The molecular rationale for the combination of polatuzumab vedotin plus rituximab in diffuse large B-cell lymphoma. British journal of haematology 199 (2) (2022)
Takaaki Fujimura, Yoriko Yamashita-Kashima, Natsumi Kawasaki, Shigeki Yoshiura, Naoki Harada, Yasushi Yoshimura
Obinutuzumab in Combination with Chemotherapy Enhances Direct Cell Death in CD20-Positive Obinutuzumab-resistant Non-Hodgkin Lymphoma Cells. Molecular cancer therapeutics 20 (6) (2021)
Mayu Arase, Yusuke Tamura, Natsumi Kawasaki, Kazunobu Isogaya, Ryo Nakaki, Anna Mizutani, Shuichi Tsutsumi, Hiroyuki Aburatani, Kohei Miyazono, Daizo Koinuma
Dynamics of chromatin accessibility during TGF-β-induced EMT of Ras-transformed mammary gland epithelial cells. Scientific reports 7 (1) (2017)